Stephan Weidinger
SESSIONS
S050 Late-Breaking Research: Session 2
Mar 10, 2024
•
1:00 PM - 4:00 PM
•
Room 20B
DISCLOSURES
AbbVie – Advisory Board(Honoraria), Investigator(Fees); Almirall – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Fees); Galderma Germany – Advisory Board(Honoraria); Leo Pharma A/S – Advisory Board(Honoraria), Investigator(Fees), Other(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Honoraria);